ADMA Biologics IncADMA Biologics is subject to a shareholder class action lawsuit alleging misleading statements about business and financial practices.
Holzer & Holzer reminds investors of upcoming lead plaintiff deadlines in shareholder class action lawsuits against BitGo Holdings, ADMA Biologics, and Erasca. The deadline for the BitGo case, which alleges misleading statements about risks from falling digital asset prices, is August 7, 2026. Deadlines for the ADMA Biologics case, covering a class period from August 9, 2024 to March 25, 2026 regarding business and financial practices, and the Erasca case, concerning ERAS-0015 between January 14, 2025 and April 26, 2026, are both August 10, 2026. Investors who purchased shares and suffered losses are encouraged to contact the firm to discuss their legal rights.
ADMA Biologics IncADMA Biologics is subject to a shareholder class action lawsuit alleging misleading statements about business and financial practices.
Erasca IncErasca is subject to a shareholder class action lawsuit concerning its drug ERAS-0015, alleging misleading statements.
BitGo Holdings, Inc.BitGo Holdings is subject to a shareholder class action lawsuit alleging misleading statements about risks from falling digital asset prices.